Program Schedule
Toggle navigation
Welcome
All sessions are noted in Eastern Time Zone. Please adjust to your time zone accordingly
Full Program
11/2/2021
11/3/2021
11/4/2021
11/5/2021
Tuesday
November 2, 2021
9:00 AM - 10:30 AM ET
100 - KEYNOTE ADDRESS: COVID-19: Pandemic to Endemic
Margaret A. Fitzgerald, DNP, FNP-BC, NP-C, FAANP, CSP, FAAN, DCC, FNAP, Founder/Family NP, Fitzgerald Health Education Associates, LLC, Greater Lawrence Family Health Center, Lawrence, MA;
Sophia Chu Rodgers, DNP, ACNP, FNP, FAANP, FCCM, Critical Care Nurse Practitioner, Lovelace Health Systems, Albuquerque, NM
×
100 - KEYNOTE ADDRESS: COVID-19: Pandemic to Endemic
CE Credit: 1.5; Rx Credit: 1
As the SARS Coronavirus-2 pandemic continues, our knowledge expands and evolves. In this presentation, find out more about the state of variant viruses, the impact of the outpatient and inpatient treatment, and how the pandemic has shifted to one of the unvaccinated and children. Advances and limitations of outpatient and inpatient therapy will be highlighted as well as updates on COVID-19 immunization. In addition, consideration for shifting from pandemic to endemic.
Learning Outcomes/Objectives:
Identify known and emerging therapies in the prevention and treatment of COVID-19 infection.
Discuss variant viruses.
Describe ways to attain global immunity.
10:45 AM - 12:00 PM ET
101 - Product Theater: Shifting Perspectives: How Do You Choose the Next Oral Therapy for T2D?
Debbie Hinnen, APN, BC-ADM, CDE, FAAN, FAADE, Advanced Practice Nurse and Certified Diabetes Educator, Memorial Hospital Diabetes Center, University of Colorado Health, Colorado Springs, CO
Sponsored by Novo Nordisk
×
101 - Product Theater: Shifting Perspectives: How Do You Choose the Next Oral Therapy for T2D?
CE/Rx will not be offered for this sponsored event.
Review the pathophysiology of T2D and the recommendations from relevant associations on the oral treatment options that should be used after metformin in the T2D treatment plan. Discuss head-to-head data for a once-daily treatment option from pivotal glycemic control trials and safety data from a cardiovascular outcomes trial, followed by dosing and administration information.
12:00 PM - 1:00 PM ET
102 - Exhibitor Showcase/Lunch/Posters
×
102 - Exhibitor Showcase/Lunch/Posters
CE Credit: 1; Rx Credit: 0
Check out the Exhibitor Showcase and Posters during this time.
1:00 PM - 2:30 PM ET
103 - Non-Pharmacologic Management of Pain
Amy Siple, FNP, President for the Kansas Advanced Practice Nurses Association, Independent Geriatric Nurse Practitioner, Wichita, KS
×
103 - Non-Pharmacologic Management of Pain
CE Credit: 1.5; Rx Credit: 0
This program explores the etiology of pain and why we respond so differently to painful stimuli. Types of pain will be discussed and the role of non-pharmacologic strategies for pain management will be addressed.
Learning Outcomes/Objectives:
Identify the purpose of pain.
Recall at least two pain assessment tools.
Report at least two reasons why there are varied response to noxious stimuli.
Identify at least two non-pharmacologic management strategies to control pain
1:00 PM - 2:30 PM ET
104 - Up and Down the GI Track: What’s New?
Peter Buch, MD, FACG, AGAF, FACP, Associate Clinical Professor of Medicine, University of Connecticut School of Medicine, ECHN Branch of the University of New England College of Osteopathic Medicine
Frank H Netter, MD School of Medicine, Haven, CT
×
104 - Up and Down the GI Track: What’s New?
CE Credit: 1.5; Rx Credit: 1
The practice of gastroenterology is always changing. What is the best treatment for eosinophilic esophagitis? Why is non-alcoholic fatty liver disease important? How does a fecal immunochemical test or a fecal DNA test compare with a screening colonoscopy? Join Dr. Peter Buch as he answers these questions and many more in a case-based format that will provide you with the latest clinical tools in gastroenterology.
Learning Outcomes/Objectives:
Identify the various treatments for eosinophilic esophagitis.
Define non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
List treatment options for each.
Describe the workup of celiac disease in a patient who is on a self-imposed gluten free diet.
Identify the "best" way to diagnose Clostridioides difficile.
Identify the therapeutic options for Clostridioides difficile.
1:00 PM - 2:30 PM ET
105 - Acute/Urgent/Emergency Care: Managing Alcohol Withdrawal Syndrome in Acute Care
Anne Dabrow Woods, DNP, RN, CRNP, ANP-BC, AGACNP-BC, FAAN, Critical Care NP, Penn Medicine, Chester County Hospital, West Chester, PA; Adjunct Faculty, Drexel University, Philadelphia, PA; Chief Nurse, Wolters Kluwer; Health, Learning, Research & Practice, Philadelphia, PA
×
105 - Acute/Urgent/Emergency Care: Managing Alcohol Withdrawal Syndrome in Acute Care
CE Credit: 1.5; Rx Credit: 1.5
Alcohol abuse is a prevalent issue and often the extent of the problem is not visible until the patient is hospitalized with another diagnosis and begins experiencing alcohol withdrawal symptoms. This session will review the etiology, presentation, diagnosis, and several management strategies for managing symptoms and complications of alcohol withdrawal.
Learning Outcomes/Objectives:
Identify the etiology and pathophysiology of alcohol withdrawal syndrome (AWS).
Identify methods to screen patients at risk for AWS and identify appropriate diagnostic studies to monitor for complications.
Identify management strategies for AWS symptoms using pharmacologic and non-pharmacologic therapies.
2:30 PM - 3:30 PM ET
106 - Exhibitor Showcase/Posters
Check out the Exhibitor Showcase and Posters during this time.
3:30 PM - 5:00 PM ET
107 - Expert Tips to Managing Adrenal Disorders in Primary and Acute Care
Christine Kessler, MN, ANP-BC, CNS, BC-ADM, FAANP, Founder, Metabolic Medicine Associates, King George, VA
×
107 - Expert Tips to Managing Adrenal Disorders in Primary and Acute Care
CE Credit: 1.5; Rx Credit: 1.5
Considered exotic by some, intimidating to many, and often misunderstood by acute and primary care providers, adrenal disorders are common, ubiquitous findings that cause and exacerbate physiological upheaval. This session will provide attendees with endocrinology tips to help better identify, diagnose, and treat adrenal insufficiency, Cushing’s syndrome, adrenal incidentaloma, and “adrenal fatigue.”
Learning Outcomes/Objectives:
Analyze clinical presentation, work-up, and preliminary treatment for chronic and acute adrenal cortical insufficiency, Cushing’s syndrome, and the incidental finding of an adrenal adenoma.
Discuss the facts and fallacies surrounding the concept of “adrenal fatigue.”
Discuss proper follow-up and referral for selected adrenal disorders.
3:30 PM - 5:00 PM ET
108 - The Choosing Wisely Campaign: Top 10 Medications to Avoid in the Geriatric Patient
Steven Atkinson, PA-C, MS, Founder and Co-Owner/Adjunct Faculty/Owner, Twin Cities Physicians, Inc. University of Utah School of Medicine/Mindful Geriatrics, LLC
×
108 - The Choosing Wisely Campaign: Top 10 Medications to Avoid in the Geriatric Patient
CE Credit: 1.5; Rx Credit: 1.5
Explore medication dosing guidelines and polypharmacy management principles to ensure safe prescribing in the geriatric patient. Review the top 10 medications to avoid and alternatives that can be equally effective.
Learning Outcomes/Objectives:
Apply age-sensitive principles for medication dosing and management to clinical scenarios.
Analyze key questions useful for identifying and managing polypharmacy in older adults.
3:30 PM - 5:00 PM ET
109 - Acute/Urgent/Emergency Care: Sepsis: What’s New in the Definition and Treatment?
Sophia Chu Rodgers, DNP, ACNP, FNP, FAANP, FCCM, Critical Care Nurse Practitioner, Lovelace Health Systems, Albuquerque, NM
×
109 - Acute/Urgent/Emergency Care: Sepsis: What’s New in the Definition and Treatment?
CE Credit: 1.5; Rx Credit: 1
Sepsis is the leading cause of death in the noncoronary ICU with mortality approaching 30% to 50%. Using a case-based scenario, this presentation will discuss the epidemiology, pathophysiology, and etiology of this deadly condition. Moreover, it will also review the Third Consensus definition of sepsis and septic shock while reviewing the latest evidence-based treatment guidelines.
Learning Outcomes/Objectives:
Discuss the epidemiology and pathophysiology of sepsis.
Define sepsis and septic shock using the Third Consensus definitions.
Describe the latest evidenced-based treatment for the treatment of sepsis.
